Basecamp Research Raises $60M to Build 'ChatGPT for Nature' and Advance AI in Biology

Basecamp Research Secures $60M in Series B Funding

Basecamp Research, a London-based startup, has successfully raised $60 million in a Series B funding round led by French venture capital firm Singular 1

1

2

2

3

3

. The company, which aims to develop artificial intelligence (AI) models for life sciences, pharma, and biotech, has now raised a total of $85 million since its inception in 2019 1

1

4

4

.

Building a 'ChatGPT for Nature'

Basecamp Research's ambitious goal is to create what they call a "ChatGPT for nature" 3

3

. Unlike traditional AI models that rely on published research papers, Basecamp is taking a unique approach by collecting primary data from diverse natural environments worldwide 1

1

3

3

.

Glen Gowers, co-founder and CEO of Basecamp Research, explained:

"We use a combination of exploration - literally going around the world to pick up data, understand hot springs, volcanoes, those sorts of things - and combine that with an artificial intelligence program that is focused purely on training massive language models" 1

1

.

Innovative AI Models and Collaborations

The company has already developed several AI models for the synthetic biology sector:

1. BaseFold: A model that reportedly outperforms Google DeepMind's AlphaFold 2 in predicting large protein structures 1

   1

   2

   2

   .

2. ZymCtrl: A next-generation end-to-end protein language model capable of generating artificial enzymes without requiring seed sequences 2

   2

   .

Basecamp Research has also entered into a multi-year collaboration with Dr. David R. Liu's laboratory at the Broad Institute of MIT and Harvard 1

1

4

4

. This partnership aims to develop novel fusion proteins and other large molecules for the next generation of genetic medicines 4

4

.

Expanding Data Collection and AI Capabilities

The Series B funding will be used to scale up Basecamp's data collection efforts, growing its foundational dataset that already contains 100 times more advanced biological systems information than public databases 2

2

4

4

. The company plans to strengthen its AI capabilities by investing in compute power and developing new foundational models for increasingly complex tasks 4

4

.

Industry Impact and Partnerships

Basecamp Research has already established over 100 partnerships across 25 countries to expand its database and deliver biological breakthroughs 1

1

3

3

. The company is working with 15 organizations to apply its AI in developing new products, including a collaboration with Procter & Gamble on sustainable fabric dyes 3

3

.

Andy Conrad, former CEO of Google's Verily Life Sciences and an investor through S32, commented:

"Basecamp Research has dedicated itself to solving some of the toughest challenges in the life sciences and is taking a truly first principles approach to address questions that the biopharma industry hasn't even known to ask" 4

4

.

As Basecamp Research continues to push the boundaries of AI in biology, its innovative approach and growing partnerships position it as a potentially transformative force in the life sciences industry.